The May 10, 2018, editorial by Kolesar et al entitled “Low-Fat Abiraterone Food Effect Is of Little Consequence” (J Clin Oncol 10.1200/JCO.2018.78.0684) was published with errors.
In the Authors’ Disclosures of Potential Conflicts of Interest section, Glenn Liu’s disclosures read as:
Glenn X. Liu
Leadership: AIQ Solutions
Stock or Other Ownership: AIQ Solutions
Research Funding: Johnson & Johnson (Inst), Novartis (Inst), Madison Vaccines, Pfizer, TRACON Pharmaceuticals
Patents, Royalties, Other Intellectual Property: US 9161720 B2: Quantitative evaluation of total tumor burden using functional and anatomical imaging (Inst)
They should have read as:
Glenn Liu
Leadership: AIQ Solutions
Stock or Other Ownership: AIQ Solutions
Consulting or Advisory Role: Janssen, Exelixis, Novartis
Research Funding: Johnson & Johnson (Inst), Novartis (Inst), Madison Vaccines, Pfizer, TRACON Pharmaceuticals
Patents, Royalties, Other Intellectual Property: US 9161720 B2: Quantitative evaluation of total tumor burden using functional and anatomical imaging (Inst)
Other Relationship: Sanofi
This has been corrected as of November 6, 2018. The authors apologize for these errors.